Olumiant (baricitinib) is an oral Janus kinase (JAK) inhibitor used to treat rheumatoid arthritis (RA), severe alopecia areata, and COVID-19 in certain hospitalized patients. It helps by blocking the proteins that cause inflammation, alleviating symptoms such as pain, swelling, and hair loss.